These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29141540)

  • 1. Polyphenols, Antioxidants and the Sympathetic Nervous System.
    Bruno RM; Ghiadoni L
    Curr Pharm Des; 2018; 24(2):130-139. PubMed ID: 29141540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural polyphenols and cardioprotection.
    Lecour S; Lamont KT
    Mini Rev Med Chem; 2011 Dec; 11(14):1191-9. PubMed ID: 22070680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants in hypertension and cardiovascular disease.
    Schiffrin EL
    Mol Interv; 2010 Dec; 10(6):354-62. PubMed ID: 21263161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of the cardiovascular protective effects of polyphenols.
    Andriantsitohaina R; Auger C; Chataigneau T; Étienne-Selloum N; Li H; Martínez MC; Schini-Kerth VB; Laher I
    Br J Nutr; 2012 Nov; 108(9):1532-49. PubMed ID: 22935143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphenol protection and treatment of hypertension.
    Hügel HM; Jackson N; May B; Zhang AL; Xue CC
    Phytomedicine; 2016 Feb; 23(2):220-31. PubMed ID: 26926184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic preventive effects of dietary polyphenols in cardiovascular diseases.
    Kishimoto Y; Tani M; Kondo K
    Eur J Clin Nutr; 2013 May; 67(5):532-5. PubMed ID: 23403879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and cardiovascular health: therapeutic potential of polyphenols.
    Khurana S; Piche M; Hollingsworth A; Venkataraman K; Tai TC
    Can J Physiol Pharmacol; 2013 Mar; 91(3):198-212. PubMed ID: 23537433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic overactivity in hypertension and cardiovascular disease.
    Manolis AJ; Poulimenos LE; Kallistratos MS; Gavras I; Gavras H
    Curr Vasc Pharmacol; 2014 Jan; 12(1):4-15. PubMed ID: 23905597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphenols and prevention of cardiovascular diseases.
    Manach C; Mazur A; Scalbert A
    Curr Opin Lipidol; 2005 Feb; 16(1):77-84. PubMed ID: 15650567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases.
    Mitjavila MT; Moreno JJ
    Biochem Pharmacol; 2012 Nov; 84(9):1113-22. PubMed ID: 22858365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases.
    Frombaum M; Le Clanche S; Bonnefont-Rousselot D; Borderie D
    Biochimie; 2012 Feb; 94(2):269-76. PubMed ID: 22133615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
    Siti HN; Kamisah Y; Kamsiah J
    Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions.
    Higdon JV; Frei B
    Crit Rev Food Sci Nutr; 2003; 43(1):89-143. PubMed ID: 12587987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphenols and cardiovascular disease: a critical summary of the evidence.
    Visioli F; Davalos A
    Mini Rev Med Chem; 2011 Dec; 11(14):1186-90. PubMed ID: 22070684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphenols and dietary antioxidant potential, and their relationship with arterial hypertension: A cross-sectional study of the adult population in Poland (WOBASZ II).
    Waśkiewicz A; Zujko ME; Szcześniewska D; Tykarski A; Kwaśniewska M; Drygas W; Witkowska AM
    Adv Clin Exp Med; 2019 Jun; 28(6):797-806. PubMed ID: 30968608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the Power of Polyphenols through Nanoencapsulation for Adjuvant Therapy against Cardiovascular Diseases.
    Trindade LR; da Silva DVT; Baião DDS; Paschoalin VMF
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments on polyphenol–protein interactions: effects on tea and coffee taste, antioxidant properties and the digestive system.
    Bandyopadhyay P; Ghosh AK; Ghosh C
    Food Funct; 2012 Jun; 3(6):592-605. PubMed ID: 22465955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
    Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
    Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.